Table 2.
Control | HFG | HFP | HFGP | |
---|---|---|---|---|
Beta-cell to alpha-cell ratio | ||||
Males | 2.71 ± 0.42 n = 3 |
2.70 ± 0.78 n = 3 |
3.08 ± 0.20 n = 4 |
5.07 ± 1.95 n = 3 |
Females | 3.94 ± 0.64 n = 5 |
4.60 ± 0.54 n = 3 |
3.36 ± 0.51 n = 3 |
— |
Alpha-cell to beta-cell ratio | ||||
Males | 0.39 ± 0.07 n = 3 |
0.48 ± 0.19 n = 3 |
0.33 ± 0.02 n = 4 |
0.26 ± 0.08 n = 3 |
Females | 0.28 ± 0.04 n = 5 |
0.22 ± 0.02 n = 3 |
0.31 ± 0.04 n = 3 |
— |
Islet cell proliferation | ||||
Males | 0.0023 ± 0.0003 n = 3 |
0.0065 ± 0.0005 n = 3 |
0.0125 ± 0.0039 n = 4 |
0.0087 ± 0.0005 n = 3 |
Acinar cell proliferation | ||||
Males | 0.0008 ± 0.00012 n = 3 |
0.0017 ± 0.0004 n = 3 |
0.1393 ± 0.0387∗†§
n = 4 |
0.0062 ± 0.0014 n = 3 |
HFG: high-fat diet during fetal life; HFP: high-fat diet during postnatal life; HFGP: high-fat diet during both fetal and postnatal life. Data are means ± SEM. *P < 0.05 versus control; † P < 0.05 versus HFG; § P < 0.05 versus HFGP.